quantisnow
FeedTopReportsPricing
⌘K
Live feed
08:06:24·111d
INSIDERFiling
AtriCure Inc. logo

Chief Operating Officer Seith Douglas J was granted 257 shares, increasing direct ownership by 0.14% to 184,370 units (SEC Form 4)

ATRC· AtriCure Inc.
Health Care
Original source

Companies

  • ATRC
    AtriCure Inc.
    Health Care

Recent analyst ratings

  • Feb 18UpdateOppenheimer-
  • Feb 11UpdateAnalyst$36.00
  • Dec 17UpdateAnalyst$40.00
  • Apr 23UpdateOppenheimer$32.00
  • Oct 23UpdateJMP Securities$60.00
  • Sep 29UpdateUBS$56.00

Related

  • PR9d
    AtriCure to Announce First Quarter 2026 Financial Results
  • SEC17d
    SEC Form DEFA14A filed by AtriCure Inc.
  • SEC17d
    SEC Form DEF 14A filed by AtriCure Inc.
  • SEC28d
    Amendment: SEC Form SCHEDULE 13G/A filed by AtriCure Inc.
  • INSIDER38d
    Chief Scientific Officer Doraiswamy Vinayak sold $149,150 worth of shares (5,000 units at $29.83), decreasing direct ownership by 5% to 96,875 units (SEC Form 4)
  • INSIDER42d
    Director White Robert S. exercised 10,000 shares at a strike of $14.99, increasing direct ownership by 9% to 122,174 units (SEC Form 4)
  • INSIDER45d
    President, CEO, & Director Carrel Michael H gifted 6,000 shares, decreasing direct ownership by 0.76% to 778,498 units (SEC Form 4)
  • INSIDER51d
    Chief Scientific Officer Doraiswamy Vinayak was granted 45,588 shares and covered exercise/tax liability with 15,585 shares, increasing direct ownership by 42% to 101,875 units (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022